The company hasn't announced additional distribution channels other than T-Cell Protect, Amazon and Alibaba. It is possible a third-party has placed bulk orders from Alibab and supplying to those countries, jacking up the price to profit from the demand for Tollovid.
Not the best of scenarios for those folks who are impacted, but also not necessarily something the company can control.
I looked into ordering a one-year supply of Tollovid Daily from Alibaba, but their minimum bulk order was much larger than a one-year supply. They don't appear to be interested in selling to individuals, only companies. Personally, I believe they may be supplying these other retailers who just popped up on the radar. Perhaps it's part of the company's international rollout, but the lack of any PR announcing it makes me suspicious. Until I see something in writing, I'm making the assumption those resellers are not authorized distributors.
JPetroInc posted a link here last week that had the price of Tollovid jacked up significantly. So it appears some are trying to profit from demand and lack of worldwide availability by buying supply and reselling at higher prices.
News 
Market Data 
Discover 
